Dr. Erich Blatter is the head of the BioPharmaceutical Technology Laboratory at GlaxoSmithKline (GSK) in Rockville, Maryland, USA. He brings over 25 years of expertise in protein chemistry, process development and technical transfer. Dr. Blatter has been involved in the development, characterization and commercialization of drugs from internal pipeline and CMO clients. Development of biosimilar drugs and scale up of commercial products are a specialty. Dr. Blatter holds a BS in biochemistry from the University of Rochester, a Ph.D. in biochemistry from Rutgers University and was a Merck postdoctoral fellow.